Patient Access:

If you are a patient with a serious or life-threatening bacterial infection with no available options for treatment, you may be eligible for expanded access phage therapy treatment.

Bacteriophages are an investigational product and have not yet been approved or evaluated for safety or effectiveness by Health Canada or the FDA. Additional information can be found on the FDA’s website:
https://www.fda.gov/news-events/public-health-focus/expanded-access

For more information about Qeen’s ability to provide and/or manufacture bacteriophages, please fill out the following form.